Supplementation with eicosapentaenoic omega-3 fatty acid does not influence serum brain-derived neurotrophic factor in diabetes mellitus patients with major depression: A randomized controlled pilot study

Neuropsychobiology

Volumn 63, Issue 4, 2011, Pages 219-223

  Bot, Mariska ^a   Pouwer, François ^a,b   Assies, Johanna ^d   Jansen, Eugène H J M ^e   Beekman, Aartjan T F ^c   De Jonge, Peter ^a,f  

^a TILBURG UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Brain derived neurotrophic factor; Depression; Diabetes mellitus; Eicosapentaenoic acid; Neuroprotection

Indexed keywords

5,8,11,14,17 ICOSAPENTAENOIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; INSULIN; ORAL ANTIDIABETIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX;

EID: 79952719963     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321804     Document Type: Article

References (22)

1. Huang EJ, Reichardt LF: Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677-736. (Pubitemid 32695243)
2. Duman RS, Monteggia LM: A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116-1127.
3. Krishnan V, Nestler EJ: The molecular neurobiology of depression. Nature 2008; 455: 894-902.
4. Brunoni AR, Lopes M, Fregni F: A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 2008; 11: 1169-1180.
5. Sen S, Duman R, Sanacora G: Serum brainderived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008; 64: 527-532.
6. Fujinami A, Ohta K, Obayashi H, Fukui M, Hasegawa G, Nakamura N, Kozai H, Imai S, Ohta M: Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: relationship to glucose metabolism and biomarkers of insulin resistance. Clin Biochem 2008; 41: 812-817.
7. Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, Fischer CP, Lindegaard B, Petersen AM, Taudorf S, Secher NH, Pilegaard H, Bruunsgaard H, Pedersen BK: Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007; 50: 431-438.
8. Venna VR, Deplanque D, Allet C, Belarbi K, Hamdane M, Bordet R: PUFA induce antidepressant- like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology 2009; 34: 199-211.
9. Wu A, Ying Z, Gomez-Pinilla F: Dietary omega- 3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 2004; 21: 1457-1467. (Pubitemid 39435321)
10. Logan AC: Omega-3 and BDNF regulation: eicosapentaenoic acid may play a key role in limitation of CNS injury. J Neurotrauma 2008; 25: 1499.
11. Kou W, Luchtman D, Song C: Eicosapentaenoic acid (EPA) increases cell viability and expression of neurotrophin receptors in retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cells. Eur J Nutr 2008; 47: 104-113. (Pubitemid 351667054)
12. Logan AC: Neurobehavioral aspects of omega- 3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern Med Rev 2003; 8: 410-425. (Pubitemid 37493870)
13. Gomez-Pinilla F: Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 2008; 9: 568-578. (Pubitemid 351873468)
14. Bot M, Pouwer F, Assies J, Jansen EHJM, Diamant M, Snoek FJ, Beekman A, De Jonge P: Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: a randomized, double-blind placebo- controlled study. J Affect Disord 2010; 126: 282-286.
15. Andrews G, Peters L: The psychometric properties of the composite international diagnostic interview. Soc Psychiatry Psychiatr Epidemiol 1998; 33: 80-88. (Pubitemid 28080588)
16. Peet M, Horrobin DF: A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002; 59: 913-919.
17. Appleton KM, Rogers PJ, Ness AR: Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010; 91: 757-770.
18. Hartong EGTM, Goekoop JG: De Montogomery- Asberg beoordelingsschaal voor depressie. Tijdschr Psychiatr 1985; 27: 657-668.
19. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ: Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998; 37: 1553-1561. (Pubitemid 28550429)
20. Karege F, Schwald M, Cisse M: Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002; 328: 261-264. (Pubitemid 34876661)
21. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM: Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143-148. (Pubitemid 34258493)
22. Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G, Karege F: Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005; 51: 234-238.(Pubitemid 40976406)